Literature DB >> 21107300

Lipids, menopause, and early atherosclerosis in Study of Women's Health Across the Nation Heart women.

Genevieve A Woodard1, Maria M Brooks, Emma Barinas-Mitchell, Rachel H Mackey, Karen A Matthews, Kim Sutton-Tyrrell.   

Abstract

OBJECTIVE: The risk of cardiovascular disease increases after menopause. Recent evidence suggests that it is possible for high-density lipoprotein (HDL) to become proatherogenic or dysfunctional in certain situations. Our objective was to evaluate whether the relationship of HDL cholesterol (HDL-C) to subclinical cardiovascular disease differed across the menopausal transition, which would provide insight for this increased risk.
METHODS: Aortic calcification (AC), coronary artery calcification (CAC), carotid plaque, and intima media thickness (IMT) were measured in an ancillary study of the Study of Women's Health Across the Nation. Women not using hormone therapy were stratified into premenopausal or early perimenopausal (Pre/EP, n=316) and late perimenopausal or postmenopausal (LP/Post, n=224).
RESULTS: The inverse relationship of HDL-C to subclinical atherosclerosis measures among Pre/EP women was weaker or reversed among LP/Post women, adjusted for age, site, race, systolic blood pressure, glucose, body mass index, smoking, menopause status, and low-density lipoprotein cholesterol. Specifically, multivariable modeling demonstrated an inverse association between HDL-C level and AC and IMT among Pre/EP women; however, the protective effect of HDL-C for AC, left main CAC, carotid plaque, and IMT was not seen in LP/Post women. In a small subset (n=53), LP/Post women had more total and small HDL particles, higher triglyceride levels, and more total low-density lipoprotein particles compared with Pre/EP women (P<0.05).
CONCLUSIONS: These results suggest that the protective effect of HDL may be diminished as women transition in menopause. Future studies should examine whether this may be due to changes in HDL size, functionality, or related changes in other lipids or lipoproteins.
© 2011 by The North American Menopause Society

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21107300      PMCID: PMC3123389          DOI: 10.1097/gme.0b013e3181f6480e

Source DB:  PubMed          Journal:  Menopause        ISSN: 1072-3714            Impact factor:   2.953


  47 in total

1.  Lipid and lipoprotein profile in menopausal transition. Effects of hormones, age and fat distribution.

Authors:  G Berg; V Mesch; L Boero; F Sayegh; M Prada; M Royer; M L Muzzio; L Schreier; N Siseles; H Benencia
Journal:  Horm Metab Res       Date:  2004-04       Impact factor: 2.936

2.  Prediction of ordinal outcomes when the association between predictors and outcome differs between outcome levels.

Authors:  Mark Lunt
Journal:  Stat Med       Date:  2005-05-15       Impact factor: 2.373

3.  Longitudinal study of risk factors for coronary heart disease across the menopausal transition.

Authors:  K A Do; A Green; J R Guthrie; E C Dudley; H G Burger; L Dennerstein
Journal:  Am J Epidemiol       Date:  2000-03-15       Impact factor: 4.897

4.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

5.  The effect of menopause on blood lipid and lipoprotein levels. The Icarus Study Group.

Authors:  D de Aloysio; M Gambacciani; M Meschia; F Pansini; A Bacchi Modena; P F Bolis; M Massobrio; G Maiocchi; E Peruzzi
Journal:  Atherosclerosis       Date:  1999-11-01       Impact factor: 5.162

6.  Cynical hostility and carotid atherosclerosis in African American and white women: the Study of Women's Health Across the Nation (SWAN) Heart Study.

Authors:  Susan A Everson-Rose; Tené T Lewis; Kelly Karavolos; Karen A Matthews; Kim Sutton-Tyrrell; Lynda H Powell
Journal:  Am Heart J       Date:  2006-11       Impact factor: 4.749

7.  Lipid changes during the menopause transition in relation to age and weight: the Study of Women's Health Across the Nation.

Authors:  Carol A Derby; Sybil L Crawford; Richard C Pasternak; Maryfran Sowers; Barbara Sternfeld; Karen A Matthews
Journal:  Am J Epidemiol       Date:  2009-04-08       Impact factor: 4.897

8.  Relation of gemfibrozil treatment and high-density lipoprotein subpopulation profile with cardiovascular events in the Veterans Affairs High-Density Lipoprotein Intervention Trial.

Authors:  Bela F Asztalos; Dorothea Collins; Katalin V Horvath; Hanna E Bloomfield; Sander J Robins; Ernst J Schaefer
Journal:  Metabolism       Date:  2008-01       Impact factor: 8.694

Review 9.  Protective effects of estrogen on the cardiovascular system.

Authors:  Michael E Mendelsohn
Journal:  Am J Cardiol       Date:  2002-06-20       Impact factor: 2.778

10.  Premature menopause in a multi-ethnic population study of the menopause transition.

Authors:  J L Luborsky; P Meyer; M F Sowers; E B Gold; N Santoro
Journal:  Hum Reprod       Date:  2003-01       Impact factor: 6.918

View more
  51 in total

1.  Decreased oxidant profile and increased antioxidant capacity in naturally postmenopausal women.

Authors:  V J Victorino; C Panis; F C Campos; R C Cayres; A N Colado-Simão; S R Oliveira; A C S A Herrera; A L Cecchini; R Cecchini
Journal:  Age (Dordr)       Date:  2012-05-28

2.  Cholesterol Efflux Capacity and Subclasses of HDL Particles in Healthy Women Transitioning Through Menopause.

Authors:  Samar R El Khoudary; Patrick M Hutchins; Karen A Matthews; Maria M Brooks; Trevor J Orchard; Graziella E Ronsein; Jay W Heinecke
Journal:  J Clin Endocrinol Metab       Date:  2016-07-11       Impact factor: 5.958

Review 3.  A clinical prescription for heart health in midlife women.

Authors:  Chrisandra Shufelt; Erika Dutra; Tina Torbati; Tina Ramineni
Journal:  Maturitas       Date:  2018-11-12       Impact factor: 4.342

4.  Women's Reproductive History and Pre-Clinical Peripheral Arterial Disease in Late Life: The San Diego Population Study.

Authors:  Yamnia I Cortés; Nisha Parikh; Matthew A Allison; Michael H Criqui; Natalie Suder; Emma Barinas-Mitchell; Christina L Wassel
Journal:  J Womens Health (Larchmt)       Date:  2018-12-01       Impact factor: 2.681

5.  Consistent ovulation may not be enough to make women healthy when approaching menopause: an update from the Study of Women's Health Across the Nation.

Authors:  Amanda A Allshouse; Alex Polotsky; Sybil Crawford; Hsiang-Yu Chen; Samar R El Khoudary; Nanette Santoro
Journal:  Menopause       Date:  2015-03       Impact factor: 2.953

6.  Obesity and altered glucose metabolism impact HDL composition in CETP transgenic mice: a role for ovarian hormones.

Authors:  Melissa N Martinez; Christopher H Emfinger; Matthew Overton; Salisha Hill; Tara S Ramaswamy; David A Cappel; Ke Wu; Sergio Fazio; W Hayes McDonald; David L Hachey; David L Tabb; John M Stafford
Journal:  J Lipid Res       Date:  2012-01-03       Impact factor: 5.922

7.  Vasomotor symptoms and lipid profiles in women transitioning through menopause.

Authors:  Rebecca C Thurston; Samar R El Khoudary; Kim Sutton-Tyrrell; Carolyn J Crandall; Ellen B Gold; Barbara Sternfeld; Hadine Joffe; Faith Selzer; Karen A Matthews
Journal:  Obstet Gynecol       Date:  2012-04       Impact factor: 7.661

8.  Meal preparation and cleanup time and cardiometabolic risk over 14 years in the Study of Women's Health Across the Nation (SWAN).

Authors:  Bradley M Appelhans; Eisuke Segawa; Imke Janssen; Lisa M Nackers; Rasa Kazlauskaite; Ana Baylin; John W Burns; Lynda H Powell; Howard M Kravitz
Journal:  Prev Med       Date:  2014-12-06       Impact factor: 4.018

9.  Increase HDL-C level over the menopausal transition is associated with greater atherosclerotic progression.

Authors:  Samar R El Khoudary; Lin Wang; Maria M Brooks; Rebecca C Thurston; Carol A Derby; Karen A Matthews
Journal:  J Clin Lipidol       Date:  2016-04-26       Impact factor: 4.766

10.  Vasomotor symptoms and lipids/lipoprotein subclass metrics in midlife women: Does level of endogenous estradiol matter? The SWAN HDL Ancillary Study.

Authors:  Alexis Nasr; Karen A Matthews; Maria M Brooks; Daniel S McConnell; Trevor J Orchard; Jeffrey Billheimer; Daniel J Rader; Samar R El Khoudary
Journal:  J Clin Lipidol       Date:  2020-07-08       Impact factor: 4.766

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.